Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.

@article{Wjdemann1999InhibitionOS,
  title={Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2.},
  author={Morten W\ojdemann and Andr{\'e} Wettergren and Bolette Hartmann and Linda Maria Hilsted and Jens Juul Holst},
  journal={The Journal of clinical endocrinology and metabolism},
  year={1999},
  volume={84 7},
  pages={2513-7}
}
Glucagon-like peptide (GLP)-2 is formed from proglucagon in the intestinal L cells and is secreted postprandially in parallel with the insulinotropic hormone GLP-1, the latter of which, in addition, acts to inhibit gastric secretion and motility by inhibiting central parasympathetic outflow. We now studied the effect of GLP-2 on gastric secretion stimulated by sham feeding to test the hypothesis that also GLP-2 acts as an enterogastrone. Eight healthy volunteers were studied twice on separate… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.

Proceedings of the National Academy of Sciences of the United States of America • 1999

Inhibition of gastric emptying by physiological and pharmacological doses of exogenous glucagon-like peptide-1 (GLP-1) outweighs insulinotropic effects in healthy normoglycemic volunteers

MA Nauck, U Niederreichholz, +3 authors WH. Schmiegel
Am J Physiol. 273:E981–E989 • 1997
View 1 Excerpt

Posttranslational processing of proglucagon and postsecretory fate of proglucagon products

JJ Holst, C Ørskov, B Hartmann, CF. Deacon
Feh mann HC, • 1997

Similar Papers

Loading similar papers…